Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Short-term (8 Week) Open-Label Study, Followed by a Long Term Evaluation, to Assess Patient-Reported Outcomes With Armodafinil Treatment (150 to 250 mg/Day) for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00228566
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:28.092703+00:00
Published At
2010-06-25T00:00:00+00:00
Record Updated At
2013-07-19
Results Posted At
2010-06-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Excessive Daytime Sleepiness", "Narcolepsy", "Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-07-19"
protocolSection.identificationModule.nctId
"NCT00228566"
protocolSection.identificationModule.officialTitle
"A Short-term (8 Week) Open-Label Study, Followed by a Long Term Evaluation, to Assess Patient-Reported Outcomes With Armodafinil Treatment (150 to 250 mg/Day) for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2010-06-25"

Study condition terms

  • Excessive Daytime Sleepiness (protocolSection.conditionsModule.conditions)
  • Narcolepsy (protocolSection.conditionsModule.conditions)
  • Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.